Federal Contract Award
Regeneron Pharmaceuticals INC
$5,565,000,000
Department of Defense · July 29, 2022 · FY2022
Award ID
CONT_AWD_W15QKN21C0014_9700_-NONE-_-NONE-
PIID
W15QKN21C0014
Obligation Amount
$5,565,000,000
Action Date
July 29, 2022
Period of Performance
January 12, 2021 → July 31, 2022
Contract Pricing Type
FIRM FIXED PRICE
Set-Aside
NO SET ASIDE USED.
NAICS Code
325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
PSC Code
6505 — DRUGS AND BIOLOGICALS
Place of Performance
TARRYTOWN, NY, USA
Recipient
Regeneron Pharmaceuticals INC →- UEI
- N3F9MH7E6HD6
- CAGE Code
- 544P9
- Parent
- Regeneron Pharmaceuticals INC
- Address
- TARRYTOWN, NY
Awarding Agency
Department of Defense
- Sub-Agency
- Department of the Army
- Office
- W6QK ACC-APG NATICK
- Funding Agency
- Department of Defense
- Funding Office
- W6DZ JPMO CBD JPMO MCS (06)
Contract Description
PRODUCTION OF THERAPEUTIC IN SUPPORT OF NATIONAL EMERGENCY RESPONSE TO CORONAVIRUS 2019 (COVID-19): IN SUPPORT OF OPERATION WARP SPEED (OWS), THE GOVERNMENT IS PURCHASING UP TO 1,250,000 DOSES OF THE EMERGENCY USE AUTHORIZATION (EUA) THERAPEUTIC.
See Every Contract Regeneron Pharmaceuticals INC Has Won
Full contracting history, year-over-year trends, subaward graph, and recompete alerts.
View Regeneron Pharmaceuticals INC Profile →